# Financial Review for R&D Grant Application
## For Review by Helen (Accountant)
### NexWave Solutions Ltd - New to R&D Grant
**Date:** 26 November 2025  
**Prepared by:** Ryo  
**Review Required By:** Mid-December 2025 (before submission)

---

## Dear Helen,

Thank you for taking the time to review the financial structure for our R&D grant application. As I briefly mentioned, we're applying for Callaghan Innovation's "New to R&D" grant to fund a 24-month clinical AI research project starting January 2026.

**Purpose of this review:** I need you to verify our financial calculations, tax treatment assumptions, and flag any issues before I submit the application in mid-December.

This document contains all the financial details you need to review. I've structured it so you don't need to refer to other documents - everything is here.

**Key areas I particularly need your expertise on:**
1. PAYE calculations for shareholder-employees
2. Contractor payment structure and withholding tax
3. Grant income tax treatment (especially with company showing losses)
4. R&D cost deductibility
5. GP revenue allocation and business expense treatment
6. GST treatment
7. Provisional tax implications

---

## What is the New to R&D Grant?

**Callaghan Innovation's New to R&D Grant:**
- Designed for companies undertaking their first structured R&D project
- Provides 40% funding (grant) + requires 60% co-funding from company
- Supports both R&D activities and capability development
- Grant funds paid quarterly in arrears (1 month after claim submission)
- Project duration: Up to 24 months

**Our Project:**
- Building NZ-sovereign clinical AI system for GP workflows
- Duration: 24 months (27 Jan 2026 - 26 Jan 2028)
- Total eligible R&D costs: $695,976
- Grant (40%): $278,305
- Co-funding (60%): $417,671 (from GP clinical income + opening cash)

---

## Key Questions for Helen - Review Checklist

Please review and confirm/flag each of the following:

### PAYE & Employment
- [ ] **PAYE calculations correct for me (Ryo) and Ting as shareholder-employees?**
- [ ] **Any shareholder-employee salary issues or risks?**
- [ ] **PAYE treatment correct given we're both working on R&D project?**

### Contractor Payments
- [ ] **Developer contractor: Is withholding tax required?**
- [ ] **Should this be treated as schedular payment?**
- [ ] **How to handle variable hours (10-40 hrs/week)?**
- [ ] **Any other contractor tax obligations?**

### Grant Income
- [ ] **Is the grant income ($278,305) taxable?**
- [ ] **If company shows losses (R&D costs > grant), how to account for grant?**
- [ ] **Any tax implications for receiving grant over 8 quarterly payments?**
- [ ] **Impact on company's overall tax position?**

### R&D Costs
- [ ] **Are all R&D costs fully tax deductible?**
- [ ] **Any limitations or restrictions on R&D expense deductions?**
- [ ] **Any clawback or recapture provisions I should be aware of?**

### GP Revenue & Business Expenses
- [ ] **GP revenue allocation correct ($375,652 over 24 months)?**
- [ ] **Business expenses at 5% of revenue ($18,783) reasonable?**
- [ ] **Correct split between business expenses vs personal?**
- [ ] **What specific GP expenses can be claimed? Any guidance?**

### GST
- [ ] **Correct GST treatment (all figures excl GST)?**
- [ ] **Do I charge GST when invoicing Callaghan for grant claims?**
- [ ] **Any GST issues with the structure?**

### Provisional Tax
- [ ] **Provisional tax implications with this income structure?**
- [ ] **Should I use safe harbour, standard, or estimation method?**
- [ ] **Any cashflow risks with provisional tax payments?**

### Other
- [ ] **Any FBT considerations?**
- [ ] **Any other tax obligations or risks I'm missing?**
- [ ] **Structure changes you'd recommend before project starts?**

---

## Financial Overview

### The Numbers (24 Months, NZD excl. GST)

**R&D Project Costs:**
| Category | Amount |
|----------|--------|
| R&D Labour - Ryo (Founder, shareholder-employee) | $299,520 |
| R&D Labour - Ting (R&D Operations Lead, shareholder-employee) | $290,640 |
| R&D Labour - Developer (Contractor) | $65,016 |
| Capability Development (third-party services) | $15,000 |
| Materials & Consumables ($1,000/month) | $24,000 |
| Hardware (immediate expenses) | $1,800 |
| **Total R&D Eligible Costs** | **$695,976** |

**Funding:**
| Source | Amount |
|--------|--------|
| Grant (40% of eligible costs) | $278,305 |
| Co-funding required (60%) | $417,671 |
| **Total Funding Needed** | **$695,976** |

**Co-Funding Sources:**
| Source | Amount |
|--------|--------|
| GP clinical revenue (net of business expenses) | $356,869 |
| Opening cash (business account) | $100,000 |
| Reserve (Ting's AU shareholder funds - not needed) | $0 |
| **Total Co-Funding Available** | **$456,869** |

**Result:**
- Total income: $100,000 (opening) + $356,869 (GP net) + $278,305 (grant) = **$735,174**
- Total R&D costs: **$695,976**
- **Final surplus: $39,198** ✓

**Cashflow Status:**
- Stays positive throughout 24 months
- Never goes negative
- Minimum cash position: $4,246 (Month 24, before final grant payment)
- Closing cash: $39,185

---

## Detailed Tax Treatment Analysis

### 1. PAYE Calculations (Shareholder-Employees)

**Ryo (Founder) - Shareholder-Employee:**
- Hours: 30 hrs/week throughout 24 months
- Total hours: 3,120 hours over 24 months
- Hourly rate: $96/hour (gross, includes 20% overhead for employer costs)
- Base rate: $80/hour + 20% overhead = $96/hour
- Monthly gross: 130 hours × $96 = **$12,480/month**
- Annual gross: $12,480 × 12 = **$149,760/year**
- **24-month total: $299,520**

**Ting - Shareholder-Employee (R&D Operations Lead):**
- Hours: 40 hrs/week throughout 24 months
- Total hours: 4,152 hours over 24 months
- Hourly rate: $70/hour (gross, includes 20% overhead)
- Base rate: $58.33/hour + 20% overhead = $70/hour
- Monthly gross: 173 hours × $70 = **$12,110/month**
- Annual gross: $12,110 × 12 = **$145,320/year**
- **24-month total: $290,640**

**Employment Status:**
- Both are shareholder-employees of NexWave Solutions Ltd
- Both on PAYE
- Both working full-time on R&D project
- Company will pay employer PAYE obligations (included in overhead calculation)

**Questions for Helen:**
1. Are these PAYE calculations correct?
2. Any issues with shareholder-employee structure for R&D grant?
3. Confirm overhead rate (20%) is appropriate for employer PAYE costs?
4. Any shareholder-employee salary risks or considerations?
5. Do we need to document these roles formally (employment agreements)?

---

### 2. Contractor Payments (Developer)

**Developer - Contractor (Not Employee):**
- Hours: Minimum 10 hrs/week, can scale 10-40 hrs/week based on workload
- Starts: Month 4 (April 2026)
- Duration: 21 months (Months 4-24)
- Hourly rate: $72/hour (includes 20% overhead)
- Base rate: $60/hour + 20% = $72/hour

**Budgeted (Minimum):**
- Minimum hours: 10 hrs/week × 52 weeks/year × 1.75 years ÷ 12 = 43 hrs/month
- Monthly cost (minimum): 43 hours × $72 = **$3,096/month**
- **21-month total (minimum): $65,016**

**Actual (Variable):**
- Hours will vary 10-40 hrs/week depending on R&D needs
- Billed monthly based on actual hours worked
- Could range from $3,096/month (10 hrs/week) to $12,384/month (40 hrs/week)
- Grant claims will reflect actual hours worked each quarter

**Questions for Helen:**
1. **Is withholding tax required for this contractor?**
2. **Should payments be treated as schedular payments?**
3. **What tax obligations do we have as the payer?**
4. **Do we need to withhold tax? At what rate?**
5. **How to handle variable monthly payments (10-40 hrs/week range)?**
6. **Does contractor need to provide IRD number?**
7. **Any other contractor tax obligations or documentation needed?**

---

### 3. Grant Income Tax Treatment

**Grant Payments:**
- Total grant: $278,305 over 24 months
- Paid quarterly in arrears (8 quarterly payments)
- Payment timing: 1 month after claim submission

**Grant Payment Schedule:**
| Quarter | Claim Month | Grant Received Month | Amount |
|---------|-------------|---------------------|--------|
| Q1 | Month 3 (Mar 2026) | Month 4 (Apr 2026) | $33,308 |
| Q2 | Month 6 (Jun 2026) | Month 7 (Jul 2026) | $36,743 |
| Q3 | Month 9 (Sep 2026) | Month 10 (Oct 2026) | $34,823 |
| Q4 | Month 12 (Dec 2026) | Month 13 (Jan 2027) | $34,623 |
| Q5 | Month 15 (Mar 2027) | Month 16 (Apr 2027) | $34,623 |
| Q6 | Month 18 (Jun 2027) | Month 19 (Jul 2027) | $34,623 |
| Q7 | Month 21 (Sep 2027) | Month 22 (Oct 2027) | $34,623 |
| Q8 | Month 24 (Dec 2027) | Month 25 (Jan 2028) | $34,939 |
| **Total** | | | **$278,305** |

**Company Financial Position:**
- R&D costs: $695,976
- Grant income: $278,305
- GP revenue (allocated to R&D): $356,869
- **Net position: Likely showing accounting losses in R&D project**

**Questions for Helen:**
1. **Is grant income taxable?**
2. **If yes, how do we account for it given company will show losses?**
3. **Can losses from R&D offset other business income (GP revenue)?**
4. **Tax treatment: Is grant ordinary income, capital receipt, or something else?**
5. **Any specific reporting requirements for government grant income?**
6. **Quarterly receipt: Any timing issues for tax purposes?**
7. **Does grant income affect tax losses or loss carry-forward?**
8. **Overall impact on company tax position over 24 months?**

---

### 4. R&D Cost Deductibility

**R&D Costs Breakdown:**
| Category | Amount | Nature |
|----------|--------|--------|
| Labour (Ryo, Ting, Developer) | $655,176 | Wages & contractor fees |
| Capability Development | $15,000 | Third-party professional services (IP lawyer, regulatory consultant) |
| Materials & Consumables | $24,000 | Cloud infrastructure, development tools, software subscriptions |
| Hardware | $1,800 | Computer equipment (RAM, monitor, iPhone for testing) |
| **Total** | **$695,976** | |

**Nature of Costs:**
- All costs directly related to R&D project
- All costs meet Callaghan Innovation's eligibility criteria
- Labour: Directly working on R&D activities
- Materials: Essential for R&D work (cloud GPU, development environment)
- Capability Development: Building R&D capabilities (IP protection, regulatory compliance)
- Hardware: Tools for R&D work

**Questions for Helen:**
1. **Are these R&D costs fully tax deductible as business expenses?**
2. **Any limitations on deductibility? (e.g., capital vs operating expenses)**
3. **Hardware ($1,800): Immediately deductible or depreciation required?**
4. **Capability Development ($15k): Fully deductible or any limitations?**
5. **Any specific R&D tax treatment or incentives available?**
6. **Should we be claiming R&D Tax Incentive separately from this grant?**
7. **Any clawback provisions if grant not spent as intended?**
8. **Timing: Deductible when incurred or when grant received?**

---

### 5. GP Revenue & Business Expenses

**GP Clinical Work (24 Months):**

**Revenue:**
- Total GP revenue: $375,652 (excl GST) over 24 months
- Monthly average: $15,652/month
- Source: Clinical work (consultations, procedures, ACC claims)
- All revenue from medical services, GST-exempt

**Business Expenses (5% of revenue):**
- Total expenses: $18,783 over 24 months
- Monthly average: $783/month
- Percentage: 5% of revenue

**Typical GP Business Expenses (examples):**
- Practice management software subscriptions
- Professional indemnity insurance
- Medical Council annual practicing certificate
- CME (Continuing Medical Education) courses
- Professional memberships (RNZCGP, etc.)
- Medical supplies for clinic
- Professional fees (accounting, legal)

**Net GP Income Available for R&D Co-Funding:**
- Gross revenue: $375,652
- Less business expenses (5%): -$18,783
- **Net available: $356,869**

**Questions for Helen:**
1. **Is 5% business expense allocation reasonable for GP practice?**
2. **What specific expenses can be claimed as GP business expenses?**
3. **Is there a better/standard percentage to use?**
4. **Correct split between business expenses vs personal?**
5. **Should some expenses be attributed to R&D company instead?**
6. **Any documentation required for expense allocation?**
7. **Tax treatment of GP income while also drawing R&D salary?**
8. **Any issues with allocating GP income to R&D co-funding?**

---

### 6. GST Treatment

**Current Assumption: All Figures Exclude GST**

**R&D Project Costs:**
- All costs shown are GST-exclusive
- Company is GST-registered
- Will pay GST on purchases (cloud services, hardware, contractor fees)

**Grant Income from Callaghan:**
- Grant is 40% of eligible costs (excl GST)
- When claiming quarterly, do we invoice Callaghan with GST added?
- Or is grant payment GST-inclusive/zero-rated?

**GP Clinical Revenue:**
- Medical services are GST-exempt (not zero-rated, exempt)
- No GST charged on GP consultations
- Cannot claim GST back on GP-related expenses

**Questions for Helen:**
1. **Confirm all R&D figures are correctly shown excl GST?**
2. **When invoicing Callaghan for quarterly claims, do we charge GST?**
3. **Is grant income GST-inclusive, zero-rated, or exempt?**
4. **Can we claim GST input credits on R&D expenses?**
5. **Any GST issues with cloud services (often charged with foreign GST)?**
6. **GST treatment of contractor payments to developer?**
7. **Any GST issues with Capability Development professional services?**
8. **Overall GST position: Will we be in refund or payment position?**
9. **Quarterly GST returns: Any special considerations with grant income?**

---

### 7. Provisional Tax Implications

**Income Sources:**

**Year 1 (2026 - 12 months):**
- GP revenue: $187,826
- Grant income: $139,497 (Q1-Q4)
- Total income: $327,323

**Year 2 (2027 - 12 months):**
- GP revenue: $187,826
- Grant income: $138,808 (Q5-Q8)
- Total income: $326,634

**R&D Costs by Year:**
- Year 1: ~$348,000
- Year 2: ~$348,000

**Net Position Each Year:**
- Year 1: $327,323 income - $348,000 costs = -$20,677 (loss)
- Year 2: $326,634 income - $348,000 costs = -$21,366 (loss)

**Current Situation (Without Grant):**
- GP income: ~$187k/year
- Paying provisional tax on this income

**With Grant (During Project):**
- Additional income: ~$139k/year
- But also additional costs: ~$348k/year
- Net effect: Accounting loss

**Questions for Helen:**
1. **What are provisional tax implications with this structure?**
2. **Do I need to increase provisional tax payments for grant income?**
3. **Can I reduce provisional tax if projecting losses?**
4. **Safe harbour vs standard vs estimation method - which is best here?**
5. **Cashflow implications: When are provisional tax payments due?**
6. **Any risk of under-estimation penalties given variable income?**
7. **Should I apply for provisional tax reduction/exemption?**
8. **How to handle Year 3 (2028) given final grant payment in January 2028?**
9. **Overall tax position: Will terminal tax be refund or payment?**

---

## Cashflow Summary (24 Months)

### Monthly Pattern

**Months 1-3 (Before grant starts, before developer):**
- GP income: $14,869/month (revenue $15,652 - expenses $783)
- R&D costs: ~$26,000/month (Ryo + Ting + M&C + CapDev setup)
- Cash burn: ~$11,000/month
- Covered by opening cash $100k

**Months 4-24 (Grant active, developer started):**
- GP income: $14,869/month
- Grant income: Quarterly injections (~$35k every 3 months)
- R&D costs: ~$28,700/month (Ryo + Ting + Developer + M&C)
- Net position: Positive due to quarterly grant injections

### Cash Position Throughout 24 Months

| Month | Opening | GP Income | Grant | R&D Costs | Closing |
|-------|---------|-----------|-------|-----------|---------|
| Month 1 | $100,000 | $14,869 | $0 | $26,590 | $88,279 |
| Month 3 | $75,558 | $14,869 | $0 | $29,090 | $61,337 |
| Month 4 | $61,337 | $14,869 | **$33,308** | $33,986 | $75,528 |
| Month 6 | $61,711 | $14,869 | $0 | $30,186 | $46,394 |
| Month 7 | $46,394 | $14,869 | **$36,743** | $28,686 | $69,320 |
| Month 12 | $48,375 | $14,869 | $0 | $29,186 | $34,058 |
| Month 13 | $34,058 | $14,869 | **$34,623** | $28,686 | $54,864 |
| Month 18 | $33,719 | $14,869 | $0 | $29,186 | $19,402 |
| Month 19 | $19,402 | $14,869 | **$34,623** | $28,686 | $40,208 |
| Month 24 | $19,063 | $14,869 | $0 | $29,686 | $4,246 |
| Month 25 | $4,246 | $0 | **$34,939** | $0 | $39,185 |

**Key Points:**
- **Never goes negative** ✓
- Minimum cash: $4,246 (Month 24, just before final grant)
- Final position: $39,185 surplus
- Quarterly grant payments are critical for cashflow
- Pattern: Cash declines between grants, recovers when grant received

---

## Total Summary (24 Months + Month 25 Grant)

**Total Inflows:**
- Opening cash: $100,000
- GP revenue (net): $356,869
- Grant income: $278,305
- **Total: $735,174**

**Total Outflows:**
- R&D costs: $695,976
- **Total: $695,976**

**Net Position:**
- Surplus: $39,198
- Closing cash: $39,185 (slight rounding difference)

---

## What I Need from Helen

**Please review and provide feedback on:**

1. **Verification:**
   - Are all calculations correct?
   - Any arithmetic errors or assumptions wrong?

2. **Tax Treatment:**
   - Is my understanding of tax treatment correct for each area?
   - Any major tax issues or risks I'm missing?

3. **Specific Concerns:**
   - PAYE calculations: Confirm these are right
   - Contractor withholding: What do I need to do?
   - Grant income: Taxable? How to account?
   - Provisional tax: What's my obligation?
   - GST: Do I charge GST to Callaghan?

4. **Recommendations:**
   - Any structure changes you'd suggest before project starts?
   - Better way to allocate GP revenue/expenses?
   - Any tax planning opportunities?

5. **Red Flags:**
   - Anything that concerns you?
   - Any risks I should be aware of?
   - Areas that need more documentation?

6. **Documentation:**
   - What documentation do I need to prepare?
   - Employment agreements for Ting?
   - Contractor agreement for developer?
   - Anything else?

7. **Timeline:**
   - Any tax-related actions needed before project starts (Jan 2026)?
   - IRD notifications or registrations required?

**Response Needed By:** Mid-December 2025 (before I submit application)

**Contact:** Please email or call if you need any clarification or additional information.

---

## Appendix: Key Numbers Quick Reference

### Team Costs (Monthly)

| Team Member | Status | Hours/Week | $/Hour | Monthly Cost |
|-------------|--------|------------|--------|--------------|
| Ryo (Founder) | Shareholder-employee (PAYE) | 30 | $96 | $12,480 |
| Ting (R&D Ops Lead) | Shareholder-employee (PAYE) | 40 | $70 | $12,110 |
| Developer | Contractor | 10-40 (min 10) | $72 | $3,096 (min) |

**Months 1-3:** $24,590/month (Ryo + Ting)  
**Months 4-24:** $27,686/month (Ryo + Ting + Developer minimum)

### Budget Breakdown (24 Months)

| Category | Amount | % of Total |
|----------|--------|------------|
| Labour (Ryo + Ting + Developer) | $655,176 | 94.1% |
| Capability Development | $15,000 | 2.2% |
| Materials & Consumables | $24,000 | 3.4% |
| Hardware | $1,800 | 0.3% |
| **Total** | **$695,976** | **100%** |

### Grant Payment Schedule

| Quarter | Amount | Cumulative |
|---------|--------|------------|
| Q1 (Month 4) | $33,308 | $33,308 |
| Q2 (Month 7) | $36,743 | $70,051 |
| Q3 (Month 10) | $34,823 | $104,874 |
| Q4 (Month 13) | $34,623 | $139,497 |
| Q5 (Month 16) | $34,623 | $174,120 |
| Q6 (Month 19) | $34,623 | $208,743 |
| Q7 (Month 22) | $34,623 | $243,366 |
| Q8 (Month 25) | $34,939 | $278,305 |

### Co-Funding Sources

| Source | Amount | % of Co-Funding |
|--------|--------|-----------------|
| GP revenue (net) | $356,869 | 85.5% |
| Opening cash | $100,000 | 24.0% |
| **Total Available** | $456,869 | 109.4% |
| **Required** | $417,671 | 100% |
| **Buffer** | $39,198 | 9.4% |

---

## Additional Context

**Company Structure:**
- NexWave Solutions Ltd (NZ registered company)
- Shareholders: Ryo and Ting
- GST-registered
- Company undertaking first structured R&D project

**Project Nature:**
- Research & Development of clinical AI system
- No revenue from R&D during 24-month period (pure R&D phase)
- Commercial revenue (if any) would come after project completion

**Grant Compliance:**
- Quarterly claims submitted to Callaghan Innovation
- Grant paid 40% of eligible costs (incurred and evidenced)
- Evidence required: Timesheets, invoices, payment proof, GST invoices
- All costs must be for eligible R&D activities

---

**Thank you for your thorough review, Helen. Please let me know if you need any additional information or clarification on any aspect.**

**Ryo**  
NexWave Solutions Ltd  
Date: 26 November 2025

---

**END OF DOCUMENT**
